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Carbon monoxide releasing molecules (CORMs) are an emerging class of pharmaceutical 
compounds currently evaluated in several preclinical disease models. There is general 
consensus that the therapeutic effects elicited by the molecules may be directly ascribed to the 
biological function of the released CO. It remains unclear, however, if cellular internalization 
of CORMs is a critical event in their therapeutic action. To address the problem of cellular 
delivery, we have devised a general strategy which entails conjugation of a CO-releasing 
molecule (here a photo-activated CORM) to the 5'-OH ribose group of vitamin B12. 
Cyanocobalamin (B12) functions as the biocompatible water soluble scaffold which actively 
transports the CORM against a concentration gradient into the cells. The uptake and cellular 
distribution of this B12
 
-photoCORM conjugate is demonstrated via synchrotron FTIR 
spectromicroscopy measurements on living cells. Intracellualr photo-induced CO release 
prevents fibroblasts from dying under conditions of hypoxia and metabolic depletion, 
conditions that may occur in vivo during insufficient blood supply to oxygen-sensitive tissues 
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Despite its reputation as a noxious gas, carbon monoxide (CO) has been recognized in recent 
years as playing a crucial role as a gasotransmitter.1 Endogenously, following heme 
degradation by inducible heme oxygenase-1 and constitutive heme oxygenase-2, CO exerts 
vasodilatory, antinflammatory and anti-apoptotic effects2 When exogenously applied, the 
diatomic molecule mediates therapeutic results in different pathologies including cancer, 
neurodegeneration, hypertension, heart diseases, liver dysfunction, inflammation and 
infections.3 The impact of CO in physiology and medicine has prompted several researchers 
to develop carbon monoxide releasing molecules (CORMs) as an alternative to the 
administration of the gas. To date the majority of CORMs are transition metal (TM) carbonyl 
complexes which under different stimuli are able to deliver CO to diseased or inflamed tissues 
in order to initiate and promote therapeutic effects at the site of disease. CO release in these 
molecules may be triggered by different strategies which include simple CO dissociation 4-6, 
redox or ligand exchange mediated processes 7-12, enzymatic triggering 13, 14 or the use of 
electromagnetic radiation.15-17
In general, at present, CORMs are not designed to target a specific receptor or intracellular 
target and their potential utility is credited to their fundamental ability to liberate CO. In some 
instance, however, cellular internalization might be fundamental for CORM activity. Robert 
Poole and his team have shown, e.g., that the bactericidal effects of CORM-3 result from its 
cellular uptake.
 
18-21 While solutions of CO gas also impair bacterial growth, they do not match 
the effectiveness of the CO releasing molecule. In this case the pronounced bactericidal 
effects of CORM-3 are ascribed to the ability of the molecule to specifically deliver 
intracellular CO to heme-containing oxidase(s) and to facilitate the electrogenic 




Within the CORM field we started to develop CO releasing molecules conjugated to 
biocompatible scaffolds,23-25 with a focus on vitamin B12, and we have recently introduced a 
cyanocobalamin (B12) Re-based CORM coordinated to the axial cyano group of the vitamin 
(B12-ReCORM-2 in chart 1).7 The molecule shows cytoprotective effects on an ischemia-
reperfusion injury model of neonatal rat cardiomyocytes (NRCs) but atomic absorption 
spectroscopy (AAS) measurements indicated no cellular uptake of the molecule.7, 26 We 
believe there are two possible explanations for this observation. On one hand it is possible 
that the CO-releasing profile of B12-ReCORM-2 (t½ of CO release = 20-30 min depending on 
conditions) does not allow sufficient time for the intracellular accumulation of the molecule. 
On the other hand, if cellular uptake of the cyanocobalamin CORM conjugate is a B12-
mediated process, it is possible that the vitamin is internalized following dissociation of the 
inorganic CORM unit. We are not aware of any studies dealing with the mechanism of 
vitamin B12 uptake in NRCs. However, in mice, cellular B12 uptake is mediated by 
transcobalamin (TC) transporters with features resembling the human homologues.27
Analysis of the structure of human transcobalamin II (TCII) in complex with B
 
12 indicates 
that vitamin docking follows replacement of the cyanide ligand on the cobalt centre with the 
aromatic imidazole group of a histidine located within the transporter binding pocket.28 It is 
thus reasonable to assume that B12-ReCORM-2 is not internalized in NRCs due to the 
replacement of the cyanide ligand and, consequently, of the entire Re-based CORM complex. 
Thus, in order to develop cobalamin scaffolds capable of intracellular delivery of appended 
CORMs, we have explored a new synthetic method, which entails the synthesis of B12 CORM 
conjugates via activation of the 5'-OH ribose group of the vitamin (see scheme 1).29  The 5'-
OH ribose group of the vitamin was selected because it has been shown to be the only 
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functional group exposed to the exterior aqueous environment when vitamin B12 is docked 
into TCII.28 This functional group should then provide the handle for the intracellular delivery 
of different appended CORMs via this general approach. 
 
Chart 1. Structures of B12-MnCORM-1 (left) and of B12
 
-ReCORM-2.  
Herein we present a novel B12-conjugated photo-activated CO-releasing molecule (B12-
MnCORM-1 in chart 1) based on the fac-[(CO)3MnI(tacd)]+ complex (where tacd = 1,4,8,11-
tetraazacyclotetradecane) appended on the ribose sugar moiety of the vitamin via the strategy 
decribed above. Live 3T3 fibroblast cellular uptake of the molecule was investigated via 
synchrotron FTIR spectromicroscopy measurements and compared to that of B12-ReCORM-
2. It is shown that B12-MnCORM-1 but not B12-ReCORM-2 is internalized in 3T3 fibroblasts. 
Furthermore, the intracelluar photo-induced CO release of B12-MnCORM-1 can be initiated 
with light of frequency in the visible region of the spectrum. Indeed liquid IR experiments and 
myoglobin assay studies indicate that CO loss may be promoted either via irradiation with a 
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LED system (maximum emission centered at 470 nm) or with a green Ar laser (formal highest 
exciting emission at 496.5 nm). The potential pharmacological value of the molecule is 
biologically demonstrated by its cytoprotective effect on a cell culture model of 3T3 
fribroblasts. Treatment with light activated B12-MnCORM-1 prevents fibroblasts from dying 
under conditions of hypoxia and metabolic depletion , conditions as may occur in vivo during 
insufficient blood supply to oxygen-sensitive tissues like heart or brain.  Finally, in our 
continuing effort to establish a general taxonomy for bioconjugated CORM species, we adopt 
here for the photoCORM presented (i.e. B12-MnCORM-1) the previously proposed 
nomenclature of the type: X-MCORM-#; where X = carrier biomolecule (here B12); M = 
transition metal (here Mn); CORM explicitly denotes the function; and # = associated 
numeric value to differentiate the molecules. 
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Results and Discussion 
Synthesis and Characterization 
PhotoCORM B12-MnCORM-1 was prepared in moderate yield in two steps from the 
reaction of the cyanocobalamin ligand 1 and the [MnIBr(CO)5] complex (see Scheme 1). 
Compound 1 was first prepared via CDT activation of the 5´-OH group of the vitamin 
followed by reaction with 1,4,8,11-tetraazacyclotetradecane (tacd). The ligand was 
obtained in good yield following HPLC purification. HPLC-MS traces recorded during the 
reaction revealed quantitative activation of B12 and the formation of two products in in a 
3:1 ratio. The mass of the two species had values of m/z = 1582.2 and m/z = 2964.2 
corresponding, respectively, to 1 and to a B12 dimer bridged by a single tacd (Scheme 1). 
B12-MnCORM-1 was then obtained via reacting 1 with [MnIBr(CO)5] in a methanol 
solution. Coordination of the pentacarbonyl complex to the pending tacd unit was carried 
out at room temperature in order to avoid a possible interaction of Mn with the cyano 
group of B12 and subsequent formation of a Co-CN-Mn adduct. The IR spectrum of B12-
MnCORM-1 showed a single νCN band at 2134 cm-1, at the same frequency of the 
corresponding stretching vibration of free B12. The absence of the characteristic shift to 
higher frequency of the νCN band (by ca. 50 cm-1), typical of Co-CN-TM adducts of 
bridging cyanides 30-32 (where TM = transition metal), is in agreement with the proposed 
structure of B12-MnCORM-1. Alongside the νCN band at 2134 cm-1 the IR spectrum of the 
photoCORM showed two νCO stretching frequencies at 2026 and 1922 cm-1 which are 















Scheme 1. Synthesis of photoCORM B12-MnCORM-1. Reagents and conditions: i) CDT, 
DMSO, 12 h, RT; ii) tacd, DMSO, 24 h, RT; iii) [MnIBr(CO)5
 
],  methanol, 24 h, RT.  
 HPLC-MS traces recorded during the formation of B12-MnCORM-1 showed the 
formation of a second product (B12-MnCORM-1a in scheme 1) in a relative 4:1 ratio. In 
our systems the two peaks were separated by ca. 1 min. Both species showed the same 
mass at m/z = 1720.8 and with the same isotope pattern expected for the desired product. 
We initially speculated that the difference in retention times might be due to different 
counter anions (i.e. Br- from [MnIBr(CO)5] and CF3CO2- in HPLC solvents) neutralizing 
the cationic photoCORM, but this conclusion was dismissed considering that our HPLC 
system is not able to discriminate such difference with an accuracy of 1 min. The two 
peaks were then separately collected, allowed to equilibrate in solution for 30 min and 
then reanalyzed. We found no evidence of an equilibrium between the two species. When 
pooled together into a single vial the HPLC trace of the resulting solution revealed the 
same separation observed in the crude mixture. This evidence pointed to two structurally 
different complexes. Attempts to obtain single crystals of the two species suitable for X-
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ray diffraction studies proved unsuccessful. However, in order to obtain insights into the 
structure of the adducts, calculations at the density functional level of theory were 
performed.  
 
The gas phase optimized structures of B12-MnCORM-1 and B12-MnCORM-1a are shown 
in figure 1. For the major product (i.e. B12-MnCORM-1), DFT calculations placed the 
[(tacd)MnI(CO)3]+ unit directly under the PO4- group of the phosphodiester linker of the 
vitamin loop. The complex is stabilized in this position by hydrogen-bonding interactions 
between two amino NH protons of the tacd ligand and the phosphate oxygen atom labelled 
O1 in figure 1 (average O∙∙∙∙H = 2.03Å) . In order to intercept other possible local 
structural minima, calculations were attempted with different starting geometries, where 
the hydrogen-bonding interactions were distrupted by rotating the [(tacd)MnI(CO)3]+ unit 
about the amide bond connecting it to B12. In all cases the starting geometries reverted 
back to the conformation shown in figure 1. It should be mentioned that in an aqueous 
environment this conformation is unlikely to persist. Solvent molecules are expected to 
strongly interact with the phosphate group therby allowing the [(tacd)MnI(CO)3]+
 
 
complex to rotate about the amide bond with a relatively low activation barrier.  
The DFT geometry of B12-MnCORM-1 was then taken as the starting point for the 
structural optimization B12-MnCORM-1a. The fac-[MnI(CO)3]+ core was first removed 
and then reintroduced with the carbonyl ligands pointing towards the the PO4- group. As 
expected, this arrangement imposed a severe steric strain on the geometry which was 
relieved in the calculations by unwinding the [(tacd)MnI(CO)3]+ complex away from the 
vitamin. Structural parametes of the carrier vitamin and of the complex were found similar 
in both species with the most notable difference being an increase in the interatomic Mn-P 
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distance by more than 2 Å in B12-MnCORM-1a. Finally this latter geometry was found to 













Figure 1. DFT calculated structures of B12-MnCORM-1 (left) and B12
 
-MnCORM-1a. 
B12-MnCORM-1 and -1a are soluble in water. As expected, owing to the chemistry of the 
fac-[MnI(CO)3]+ core, the compounds are stable in solution and as a solid if kept in the 
dark. The UV-visible spectra of B12-MnCORM-1 and -1a are virtually identical to that of 
native B12 with the exception of a slightly pronounced absorption in the soret region 
attributed to the presence of the fac-[(tacd)MnI(CO)3]+
 
 (2) complex (vide infra). Over a 
period of 24h, no change was observed in the spectrum of a solution of the photoCORMs 





  P 
  Mn 
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CO Releasing Properties of B12
The photo-induced carbon monoxide releasing properties of B
-MnCORM-1. 
12-MnCORM-1 were 
evaluated by liquid IR spectroscopy and the myoglobin assay (figure 2).21, 25 Two sets of 
experiments were performed using two different light sources. The UV-vis spectrum of 
the fac-[(tacd)MnI(CO)3
 
]Br complex (2) was first determined in order to select the 
appropraiate irradiation wavelength. In an unbuffered aqueous solution 2 shows a 
maximum absorption centered at 388 nm. DFT calculations indicated that this absorption 
is composed of several excitations of which the seven major ones involve HOMO 
(HOMO-3 to HOMO) to LUMO (LUMO to LUMO+9) transitions between orbitals 
mainly of metal character. In oder to promote CO loss from the photoCORM, initially a 
LED system (blue visible light with maximum emission at 470 nm) was employed. The 
emission profile of this LED systems shows a significant overlap with the absorption band 
of 2 (figure 2A). In a second instalment, experiments were performed using a green Ar 
laser. In this case, laser emissions with fequencies higher than 658.9 THz were eliminated 
via the use of a 455 nm optical cutoff filter positioned between the laser source and the 
sample. Analysis of the superiposition of the laser emission lines and the absorption 
spectrum of 2 reveals an overlap of six distinct excitation wavelengths ranging from 457.9 
to 496.5 nm (see figure 2A)   
The behaviour and CO releasing properties of B12-MnCORM-1 were first studied in a 
methanol solution by IR spectroscopy using an in situ IR deep probe. In solution the 
complex shows two characteristic νCO stretching frequencies at 2031 and 1930 cm-1. In 
the dark no change was observed over a 12h period. Upon exposure to the LED source the 
two peaks began to decrease steadily, disappering after 3h of illumination (figure 2B). No 
intermediates were observed during the photolysis. When the green Ar laser was used a 
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similar behaviour was observed but with much slower kinetics of CO release.  
 
Under experimental conditions of a typical myoglobin assay, irradiation of B12-
MnCORM-1 with the LED source elicited the spectral changes associated with CO 
release. This was determined by following the absorption spectra of the Q band of deoxy-
myoglobin (deoxy-Mb) at 551 nm as it converted to carbon monoxide myoglobin (MbCO) 
with two maximal absorption peaks at 540 and 578, respectively (figure 2C). The 
conversion proceeded cleanly with six isosbestic points clearly visible in the spectrum. 
When experiments were performed under conditions of a limiting amount of B12-
MnCORM-1, taking into account the molar extinction coefficient of MbCO, it was found 
that approximately 3 mol of CO were released per mole of the corresponding complex 
within 1 hour. To confirm the identy of the resulting species, following photo-induced 
carbon monoxide release, samples of the photoCORM were analyzed by HPLC-MS. It 
was determined that the only vitamin B12 species present in solution was the free ligand 1, 
indicating complete dissociation of the fac-[MnI(CO)3]+
 
 core. 
Under similar conditions, the spectrum of the conversion of deoxy-Mb to MbCO 
promoted by irradiation of B12
 
-MnCORM-1 showed disticly different features when the 
Ar laser was used (figure 2D). Qualitatively the spectral changes confirm CO release by 
the photoCORM and formation of MbCO. However, after prolonged exposure to the 
electromagnetic radiation, photolysis of the Mb-bound CO was also observed. This 
process was evidenced by the appearance after 2h of irradiation, of a small peak at 640 





Figure 2. A: UV-visible spectrum of 2 in an unbuffered aqueous solution (red); emission 
spectrum of LED source (black); relative intensity of green Ar laser emission lines (green). B: 
changes in the liquid IR spectrum of a 4 mM solution of B12-MnCORM-1 exposed to LED 
source. C: conversion of deoxy-myoglobin (deoxy-Mb) to carbon monoxide myoglobin 
(MbCO) by B12-MnCORM-1 exposed to LED source (20 μM Mb and photoCORM, 25°C, 
0.1 M phosphate buffer pH 7.4, spectra intervals = 5min). D: conversion of deoxy-myoglobin 
(Mb) to carbon monoxide myoglobin (MbCO) by B12-MnCORM-1 exposed to green Ar laser 
(20 μM Mb and 60 μM photoCORM, 25°C, 0.1 M phosphate buffer pH 7.4, spectra intervals 
= 30min). Insert shows the formation of metmyoglobin (MetMb) after prolonged exposure to 
the light source. 
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Fibroblast Uptake and Localization of B12-MnCORM-1 and B12
We studied the interaction of B
-ReCORM-2.  
12-MnCORM-1 and B12-ReCORM-2 with the 3T3 NIH 
line as a cellular model system and used Synchrotron IR Spectromicroscopy to follow its 
real time uptake and subcellular localization. IR spectroscopy is capable of detecting 
molecular chromophores, without any need of exogenous labelling, and to provide 
structural information about the same.34 When implemented as a spectromicroscopy 
technique, it allows us to monitor molecular distribution and structure in microscopic 
samples.35, 36 The use of a synchrotron light source further enhances the performance of 
the technique by improving the signal-to-noise ratio (SNR) when measuring at diffraction 
limited spatial resolution.37 In measuring cellular spectra, IR spectromicroscopy records 
spectral contributions from all molecules in the sample. The complexity of cellular 
composition is reflected in the complexity of  the resulting IR spectra.38, 39 However, the 
carbonyl stretching vibrations appear in a spectral region, between 1800 cm-1 and 2100 
cm-1
 
, which is clear of other absorptions from the most abundant cellular components. 
3T3 cells were grown as an adherent phenotype on CaF2 optical slides, transparent to IR 
radiation in the spectral range above 950 cm-1. The cells were washed with medium 
containing 1mM of either B12-MnCORM-1 or B12-ReCORM-2 under dim light, enclosed 
in a thermostatic holder set at 37 °C and moved to the IR microscope for inspection. A 
single cell was selected under dim light and its IR absorption spectrum recorded as a 
function of time. Difference spectra are calculated by subtracting the first spectrum of the 
sequence from the following ones. Positive bands correspond to the accumulation or 
formation of molecules that occurs in the probed volume, inside or in the proximity of the 
cell, while negative bands correspond to the expulsion or decomposition of molecules in 
the same volume. 
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When 3T3 fibroblasts were treated with a solution of B12-ReCORM-2 no cellular 
accumulation was observed over a period of several hours of incubation. However, when 
the same cells were incubated with B12-MnCORM-1 difference IR spectra showed slowly 
evolving spectroscopic changes. The spectra are shown in figure 3. Most changes 
correspond to variations of absorbance in the range 10-4 - 10-3 au per minute, above the 
level of noise. It is to be noted that the use of a bright synchrotron source of IR light has 
been critical in obtaining sufficient signal-to-noise in the measurement of the weak 
changes associated with real time uptake in Figure 3. The spectral region between 1800 
cm-1 and 2100 cm-1, where carbonyl absorptions are expected, displays a series of positive 
and negative variations. Only two bands are expected for the E and A1
 
 transitions of a 
facial tri-carbonyl complex, indicating that chromophores other than the CORMs are 
contributing to the variations.  
We used a two-dimensional correlation spectroscopic (2D-COS) analysis to simplify the 
picture by identifying sets of bands attributable to specific chromophores. This approach 
has been described in detail elsewhere.40 2D-COS was introduced by Noda as a tool to 
analyze complex spectral patterns that evolve as a function of a parameter.41 The analysis 
provides a quantitative assessment of the phase relationship existing between the evolving 
bands of chromophores and allows its parameterization. In applications to complex 
biological systems it has been shown that the analysis allows the identification of bands 
arising from the same molecular chromophore.40, 42 Additional features that make 2D-COS 
useful for the analysis of cellular spectral patterns are the improved spectral resolution 
and the possibility to extract weak bands evolving on a noisy background.40, 43
 
 
The results of a 2D-COS analysis of the spectral changes from figure 3 are shown in 
16 
 
figure 4, with the 2D synchronous (A) and asynchronous (B) correlation plots shown 
separately. Bands from the same chromophore display synchronous correlation, change 
perfectly in phase and give rise to matching positive off-diagonal peaks in the 
synchronous plot. For the same reason, bands arising from the same chromophore do not 
display any off-diagonal peaks in the asynchronous plot. The pair-wise analysis of peak 
correlations allows the clustering of peaks arising from the same chromophore.  
 
Applying this analysis to the plots in figure 4 shows that six different molecular species 
are responsible for the spectral variations of figure 3. The largest ensemble of peaks is 
assigned to water vapor, arising from small changes in the atmosphere surrounding the 
sample chamber. An additional ensemble of peaks is dominated by the two peaks at 1931 
cm-1 and 2027 cm-1, at frequencies characteristic for the E and A1 transitions of B12-
MnCORM-1. These peaks are positive, indicating that the concentration of B12
 
-
MnCORM-1 is increasing in the measured volume.  
From uptake measurements, it is assumed that the observed concentration increase is 
localized within the cell or at its surface. Detailed mapping of the chromophore, as 
described later, is necessary to clarify the cellular distribution of the compound. By using 
Lambert Beer’s Law with absorption coefficients (ε) of 150 mM-1μm-1 (A1) and 170 mM-
1μm-1 (E) we can estimate a nominal rate of accumulation of 3 μM/min.  This nominal rate 
is to be interpreted as an averaged concentration change over the volume probed by the 
beam. This volume includes the medium above and surrounding the cell. The effective 
concentration inside the cell can be extracted by knowing the ratio of the cell volume to 
the volume probed by the beam. Although the exact value varies from cell to cell, an 





















Figure 3. Accumulation and subsequent photolysis of B12-MnCORM-1 in a single 3T3 
fibroblast. Pictures show the time evolution of the IR spectrum of a 3T3 cell incubated 
with B12-MnCORM-1 in a 2D (bottom) and a 3D (top) representation. The green line in 
the frame of the 2D spectrum is a “cross section” along the time direction shown in the 
plot; the horizontal red line (hv) at ca. 49 min indicates start of illumination by xenon 
light. a.u. = arbitrary absorbance units. Marked peaks correspond to the E and A1 
stretching modes of the fac-[MnI(CO)3]+ core.   
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Figure 4. Results of 2D-COS analysis of the spectra reported in figure 3 Top: 
Synchronous Correlation. Bottom: Asynchronous Correlation.
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The cyanide ligand of the corrine complex has an absorption band, corresponding to the 
stretching of the CN triple bond, at 2132 cm-1 in solution. This is a spectral region 
relatively clear of other molecular absorption bands. Nonetheless, no bands associated to 
cyanide are seen in the spectra of figure 3. 2D-COS plots allow extracting weak evolving 
bands from noisy backgrounds, taking advantage of their higher degree of auto correlation 
relative to noise. Indeed analysis of the synchronous correlation plot reveals the presence 
of a contribution from a band at 2132 cm-1. The band evolves in phase with the carbonyl 
bands at 1931 cm-1 and 2027 cm-1
 
, although with small off-phase component observed in 
the asynchronous plot. 
After reaching a cellular concentration of 0.24 mM B12-MnCORM-1, we exposed the 
sample to the light of the microscope halogen illuminator, at 75% of total power, while 
continuously measuring the IR absorption spectrum. Under these conditions the carbonyl 
bands at 1931 cm-1 and 2027 cm-1 disappear over the course of ten minutes, in agreement 




To obtain information on the localization of B12-MnCORM-1 within the cell, in separate 
experiments we performed IR mapping at diffraction limited spatial resolution of a cell 
after uptake of the compound. A sample of 3T3 cells was exposed to a 1 mM solution of 
B12-MnCORM-1 for a few hours, to ensure completion of the uptake process and 
stabilization of the spectra. A final average concentration of 1.0 - 1.5 mM B12-MnCORM-
1 within cell was achieved. One cell was then selected and mapped by using a 36x (0.5 
NA) Schwarzschild objective and a confocal aperture set at 5 x 5 µm2. Under these 
conditions, spatial resolution R at 2000 cm-1 (λ = 5 µm), according to Rayleigh’s criterion,  
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is R ~ λ = 5 µm. At such concentrations of B12
 
-MnCORM-1 spectra with a very good 
signal-to-noise ratio are obtained (see supplementary FigureS6). This allows us to 
partially resolve the spatial distribution of carbonyl absorptions inside and in the 
proximity of the cell. An adherent 3T3 cell is about 10-15 µm by 25-30 µm in size, 
excluding the cellular extensions, with a nucleus about 10-15 µm across, approximately in 
the center of the extended cell (figure 5). It is therefore possible to resolve the distribution 
of the carbonyl bands between the inside and outside of the cell and between the 
cytoplasmatic and nuclear regions. However, resolution is insufficient to resolve smaller 
organelles.  
The maps of figure 5 show that carbonyl bands are present throughout the interior of the 
cell but much stronger in the central region of the cell, corresponding to the putative 
location of the nucleus. Caution is necessary in interpreting this observation 
quantitatively. The topography of an adherent fibroblast cell is characterized by a thicker 
bulge, corresponding to the nuclear location, surrounded by a much thinner cytoplasmic 
region that slopes towards the edges of the cells. Therefore, the optical path through the 
adherent cell is longer in the nuclear region: a molecule with a uniform cellular 
distribution would still show higher absorbance in the nuclear region. Two conclusions 
can be extracted from the maps of figure 5. The first one is that the carbonyl bands are 
clearly located within the cell, thus confirming that uptake has taken place. The second 
one is that their accumulation is not restricted to the cytoplasm, or a clear gap would 
appear in the nuclear location.  
 
In order to confirm cellular and nuclear accumulation of B12-MnCORM-1, atomic 
absorption measurements (AAS) were performed on 3T3 fibroblasts incubated with 100 
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µM the compound for 6h (see experimental section and supporting information). Analysis 
of the Mn content in whole cells revealed a total intracellular concentration of ca. 10 
mM/mg protein of B12-MnCORM-1. Partitional analysis of the nuclear and of the 
cytosolic fractions showed a relative Mn concentration of 0.73:1. By considering 
estimates of the relative cellular and nuclear volumes of mouse fibroblasts,44, 45
 
 the above 
ratio may be as high as 0.8:1, indicating overall a substantial nuclear accumulation of the 












Figure 5. Optical image of a 3T3 fibroblast incubated with B12-MnCORM-1. Top and 
bottom inserts show images reconstructed from integrating the intensities of the carbonyl 
stretching vibrations at frequencies of 2018 and 1900 cm-1
 
 respectively. The scale 
represents units of integrated band area in an absorbance vs. wavenumber spectrum. Nc = 
cell nuclear area. 
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In addition, the maps are consistent with the possibility that a larger amount of carbonyl 
complex might have accumulated in the nucleus. A nuclear or perinuclear accumulation of 
metal carbonyl complexes has already been proposed by other authors using a variety of 
vibrational imaging techniques.46-48
 
  However, this cannot be confirmed quantitatively 
without having an exact model of cellular topography to correct for cell thickness effects.   
It is notable that the carbonyl bands mapped in figure 5 have different positions than the 
ones observed during uptake, the former being at 1900 cm-1 and 2018 cm-1 and the latter 
being at 1931 cm-1 and 2027 cm-1
 
. The difference may be attributed to a variation in the 
secondary coordination sphere of the metal carbonyl complex reflecting perhaps the 














Cytoprotective effects of B12
In contrast to B
-MnCORM-1 tested on fibroblast cell culture 
12-ReCORM-2 that was not taken up by 3T3 cells, B12-MnCORM-1 was 
accumulating within the cells over about one hour's time (figure 3). Judging from the intensity 
of the carbonyl frequencies characteristic for B12-MnCORM-1 recorded inside and outside a 
fibroblast after incubation in 1 mM solution of B12-MnCORM-1 for a few hours, its 
intracellular signal intensity was roughly 10 times higher than outside (figure 5). This was 
estimated to correspond to a final concentration of 1.0 - 1.5 mM B12-MnCORM-1 within the 
cell. It looks as if the compound was also taken up by the cell nucleus, although its subcellular 
repartition cannot be determined unequivocally by present day technology. Nevertheless, the 
results indicate that B12-MnCORM-1 is actively transported against a concentration gradient 
into the cells. In fact, the cellular uptake of vitamin B12 has recently been shown to involve a 
complex transport machinery involving more than 15 gene products.49 Once inside, CO may 
be liberated from the compound by photolysis with white light as demonstrated in figure 3. 
The spectral changes recorded over the cell area caused by CO photolysis are further proving 
the intracellular localization of B12
The cytoprotective properties of B
-MnCORM-1. 
12-MnCORM-1 were tested on the 3T3 fibroblast cell 
culture system. 10 minutes after administration of 30 µM B12-MnCORM-1 half of the culture 
dishes were exposed to light (xenon lamp at a distance of 10 cm for 15 min) to photolyse CO, 
while the other half was kept in the dark (see Experimental Section). The results of counting 
live and dead cells after treating fibroblast cultures with B12-MnCORM-1 are summarized in 
figure 6. Treatment of fibroblast cultures with 30 µM B12-MnCORM-1 displayed no overt 
cytotoxicity as judged from viable cell numbers and cytochemical morphology. In analogy to 
the estimate of a cellular uptake rate of around 6 µM per minute in single fibroblasts (see 
above) in the presence of 1 mM B12-MnCORM-1 (figures 3 and 5), the concentration of the 
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compound in the cultured cells exposed to 30 µM B12-MnCORM-1 may reach 10-20 µM 
within 10 minutes when illumination started. Thus, in the fibroblast culture experiments the 
B12-MnCORM-1 may be present inside and outside the cells. However, during the time 
course of 48 hours the compound may further accumulate inside the cells with advancing 
time. Illumination may thus activate B12
During the time course experiments, the fibroblasts in culture settled down to the bottom of 
the dishes. Nuclear staining with Hoechst-33342 yielded the total number of attached cells, 
while PI stained the fraction of cells destined for death whose surface membrane was 
lesioned. The lesioned PI-positive cells gradually detached from the bottom of the dishes. 
This is demonstrated in figure 6A where attached cells under normoxia proliferated with time 
displaying saturation characteristics leveling between 400 and 500 cells per culture dish. 
Under hypoxia and metabolic depletion cell numbers followed a similar course but after 26 
hours they began to decline significantly. On the other hand, total numbers of cells attached to 
the substratum in cultures under hypoxia and treatment with light-activated B
-MnCORM-1 inside and outside the cells and the CO 
released outside will enter cells by permeating through the surface membrane and contribute 
to the cellular effects. 
12-MnCORM-1 
remained relatively low, oscillating between 100 and 200. At 41 hours statistic t-values of 
total cell numbers for normoxic controls versus both hypoxic with and without B12-
MnCORM-1-treatment reached levels which corresponded to p<0.01 (figure 6A asterisk). 
Under hypoxia the fraction of PI-positive dead cells increased from 26 hours till the end of the 
experiments (figure 6C), thus mirroring the decline of the numbers of attached cells under 
hypoxia. Significances of dead cell fractions between hypoxic cultures versus normoxic and 
hypoxic cultures treated with B12-MnCORM-1 could not be established, because the dead cell 
fractions were quite variable. This might be due to the variable number of cells that were 
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detached from the substratum. Consequently, the numbers of "dead cells still attached" may 
represent a variable underestimate of the actual amounts of dead cells. 
 
Figure 6. Effects of B12-MnCORM-1 on fibroblast cell cultures under different conditions. 
Normoxia: 5 mM glucose, 10% fetal bovine serum (FBS), pH 7.4 and 37ºC. Hypoxia: 0.2% 
O2, 5% CO2 and 94.8% N2, pH 7.4 and 37ºC, no glucose, no FBS. B12-MnCORM-1 (30 µM) 
was added in the dark and activated by xenon lamp for 15 min when required. Time course of 
total number of cells attached to the substratum (A) and relative amount of dead cells (C) 
under conditions as indicated after staining with Hoechst-33342 and propidium iodide (PI). 
Number of attached cells (B) and percentage of dead cells (D) treated with inactive B12-
MnCORM-1 and with light activated B12-MnCORM-1 at 48 hours under normoxic or 
hypoxic conditions as indicated. Numbers of cells are total counts in 4 x 0.5 mm2 of pre-
determined microscope areas per culture dish (see Experimental Section). Experiments in (A 
and C) represent different series than in (B and D), but in all cases the number of independent 
experiments is 5. For further explanations see text. Data are means ± SEM. One-way ANOVA 
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with post-test Bonferroni correction (A and C) or non-paired Student's t-test (B and D) was 
used for assessment of significance. Asterisk in (A) at 41 hours of normoxia denotes t-values 
in comparison to both lower curves corresponding to p<0.01. Differences between normoxic 
and hypoxic conditions in (B) all have p<0.01. 
 
 
Comparison of the same parameters between treatment with non-activated B12-MnCORM-1 
and with light-activated B12-MnCORM-1 is shown in figure 6B and 6D for cultures after 48 
hours under normoxic or hypoxic conditions. In this experimental series the normoxic and 
hypoxic control values of attached cells reached near 700 and 200, respectively (figure 6B). 
Addition of non-activated or light-activated B12-MnCORM-1 did not significantly change 
either of the attached cell number values. Of note, B12-MnCORM-1 only slightly reduced the 
attached cell number from ~700 close to ~600 under normoxia, while under hypoxia the cell 
numbers remained at ~240 both with non-activated as well as with light-activated B12-
MnCORM-1. Turning to the fractions of PI-positive dead cells still attaching to the 
substratum, light-activation of B12-MnCORM-1 significantly reduced the number of dead 
cells under normoxia when compared to the cultures with non-activated B12-MnCORM-1 (p = 
0.028). Under hypoxic conditions there was a trend towards the same outcome with p = 0.088. 
However, a significant reduction of dead cells by activated B12-MnCORM-1 was also 
observed in comparison to hypoxia alone (p = 0.0065). Generally, the number of dead cells 
was below 5% under all conditions of normoxia (figure 6C and 6D). Taken together, activated 
B12
The fibroblasts in culture that settled to the bottom of the dish, developed a dense actin stress 
-MnCORM-1 protected fibroblasts in culture from dying when the cells were under severe 
stress induced by hypoxia and metabolic depletion.  
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fiber network, which supposedly attaches to the substratum via focal adhesion plaques 
involving complexes with over half a dozen proteins, including integrin, talin, paxilin, 
vinculin, alpha-actinin, fokal adhesion kinase and others.50, 51
Phalloidin binds to filamentous F-actin and prevents its depolymerisation. Phalloidin 
conjugated with green Alexa Fluor® 488 (0.1 µM final concentration) was used to visualize 
the F-actin cytoskeleton in combination with nuclear staining with blue Hoechst-33342. Prior 
to staining cell cultures kept for 48 hours were washed twice with PBS, fixed with 4% 
paraformaldehyde and permeabilised with 0.2% Triton X-100 (figure 7). Under normoxia the 
dense and confluent cell culture exhibited an intensive green cytoskeletal staining (figure 7A). 
Under hypoxia either with or without non-activated B
 In addition, the stress fibers 
comprise smooth muscle alpha-actin and non-muscle myosin. The cytoskeletal development 
when fibroblasts attach to the substratum is considered to represent a differentiation step 
transforming fibroblasts to contractile myofibroblasts. Such actin stress fibers are virtually 
absent in the detached cells prone to death. Thus the occurrence of stress fibers may be taken 
as marker for cell attachment to the culture dish.  
12-MnCORM-1 cells were fewer and 
exhibited an altered morphology (figure 7B and 7C). In both cases the cells were considerably 
larger than under normoxia. This may be no surprise, since in the normoxic confluent culture 
cell-cell contacts inhibited individual cell growth, while the fewer cells in hypoxia without 
such contacts were not inhibited and may have further grown, in fact, they hypertrophied. 
Moreover, many cells displayed rhomboid and triangular shapes with intense actin staining 
along the edges. In addition a number of cells exhibited long spindle-like extensions. Taken 
together, the cellular appearance in figure 7B and 7C left the impression as if the cells under 
hypoxia were in the process of retracting from their original position on the substratum and 
thus progressing towards cell death. In contrast, treatment with light-activated B12-
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MnCORM-1 significantly reduced cell death under the harsh conditions of hypoxia and 
metabolic depletion (neither glucose nor FBS) (figure 7D). In this particular culture, cell size 
and density was almost comparable to that under normoxia (figure 7A) while the actin 
cytoskeleton was considerably less prominent under hypoxia with activated B12-MnCORM-1. 
The actin cytoskeleton was somewhat variably expressed in cells of different sectional 
regions, more strongly in the central parts and less so in the peripheral regions. Why light-
activated B12-MnCORM-1, beside its beneficial life saving effect, on average reduced cell 






Figure 7. Representative histochemical staining of fibroblasts after 48 hours in culture under 
normoxia (A), hypoxia (B), treated with non-activated B12-MnCORM-1 (C) and with light-
activated B12
 
-MnCORM-1 (D). Staining of actin stress fibers in green with Alexa Fluor® 488 
phalloidin and of nuclei with Hoechst-33342 in blue. Scale bar of 100 µm (A) is also valid for 
(B, C and D). For detailed description see text. 
Conclusions 
In conclusion, we have presented a novel B12-conjugated photo-activated CO-releasing 
molecule appended on the ribose sugar moiety of the vitamin. Live 3T3 fibroblast cellular 
uptake of the molecule, investigated via synchrotron FTIR spectromicroscopy measurements, 
revealed that B12-MnCORM-1 was actively transported and internalized in 3T3 fibroblasts. 
The intracelluar photo-induced CO release of B12-MnCORM-1 could then be initiated with 
light of frequency in the visible region of the spectrum. The potential pharmacological value 
of the molecule was demonstrated by its cytoprotective effect on a cell culture model of 3T3 
fribroblasts. The fibroblast cell culture system presented a sensitive model to test 
cytoprotective properties of CO-releasing transition metal complexes such as MnCORM 
coupled to cyanocobalamin (B12). In the case of B12-MnCORM-1 the cobalamin moiety helps 
the compound to accumulate in the fibroblasts via a complex transport machinery that 
operates against a concentration gradient. Once inside the cell, B12-MnCORM-1 can be 
activated by light photolysis to release CO. We have shown that light-activated B12-
MnCORM-1 protects fibroblasts from death under conditions of hypoxia and metabolic 
depletion. Without light activation B12-MnCORM-1 has no protective properties. The 
strenuous cell culture conditions at insufficient supply of oxygen and nutrients may mimic 
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comparable situations during hypoperfusion of oxygen-sensitive tissues such as the heart or 
brain in vivo. 
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Experimental Section  
Chemicals and solvents for synthesis were purchased from standard sources. All synthesis 
were performed under an inert N2 atmosphere unless otherwise noted. Elemental analyses 
(EA) were performed on a Leco CHNS-932 elemental analyzer. Atomic absorption 
measurements were carried out using a Varian AA 240FS fast sequential atomic 
absorption spectrometer. Solid state IR spectra were recorded in a PerkinElmer Spectrum 
BX FT-IR spectrometer. Liquid IR spectra were measured with an in situ deep IR probe of 
a Mettler Toledo ReactIR iC10 system. UV/Vis spectra were taken on a Perkin Elmer 
Cary 50 spectrometer with a Peltier thermostat. Mass spectra were recorded in the positive 
mode on an Esquire HCT from Bruker (Bremen, Germany) with electrospray ionization 
(ESI). High-resolution electrospray mass spectra were recorded on a Bruker maXis 
QTOF-MS instrument (Bruker Daltonics GmbH, Bremen, Germany). The samples were 
dissolved in a 1:1 mixture of MeOH and 0.1% formic acid and analyzed via continuous 
flow injection at 30 µL/min. The mass spectrometer was operated in positive ion mode 
with a capillary voltage of 4 kV, an endplate offset of –500 V, nebulizer pressure of 5.8 
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psig, and a drying gas flow rate of 4 L/min at 180°C. The instrument was calibrated with a 
sodium formate solution (500µl H2O : 500µl iPrOH : 20ul HCOOH : 20µl 0.1M NaOHaq
Analytical HPLC method.  
). 
The resolution was optimized at 30’000 FWHM in the active focus mode. The accuracy 
was better than 2 ppm in a mass range between m/z 118 and 2000. All solvent used were 
purchased in best LC-MS qualities.  
Instrument: MERCK HITACHI LaChrom with a D-7000 interface coupled with a Diode 
Array detector L-7455 and a pump L-7100 system. Column: Macherey-Nagel, EC250/3 
Nucleosil 100-5 C18. Flow rate 0.5 mL/min. Absorbance monitored at 250 nm. Solutions: 
A: 0.1% trifluoroacetic acid in water; B: methanol. Chromatographic method: 0-5 min: 
isocratic flow of 75% A-25% B; 5-40 min: linear gradient to 100% B. 
Atomic Absorption Spectrometry.  
The 3T3 cells were plated in fifteen 6cm ǿ Petr -dishes and grown in DMEM medium 
supplemented with 10% foetal calve serum and penicilin-streptomycin mixture to 70% 
confluence. Six of them were then treated with 100 μM B12-MnCORM-1 dissolved in 
DMEM whereas the other six plates were used as control. Treatment of 3T3cells with B12-
MnCORM-1 in the absence of light lasted 6 h. Thereafter the medium was collected for 
analysis and the cells were washed three times with PBS. After the removal of PBS, three 
Petri-dishes per condition were wet-burned with concentrated trace metal-free HNO3 (300 
µl total volume) and the retained total intracellular B12-MnCORM-1 content was 
measured using atomic absorption spectrophotometry. The other three samples per 
condition were placed on ice and treated for 10 minutes with a cell lysis buffer containing 
0.27 M sucrose, 2 mM EDTA (pH 8.0), 0.1% NP-40, in 0.6 M KCl, 150 mM NaCl, 150 
mM HEPES (pH 7.5). This buffer perforated plasma membranes and released cytosolic 
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components leaving nuclear membranes unaffected. This protocol was successfully used 
for isolation of nuclear fraction in various cell lines and primary cell cultures.52 The lysis 
buffer containing cytosolic proteins was then removed and the remanining perforated cells 
washed with PBC and burned with HNO3
 
. Cells in the remaining three Petri dishes were 
washed with PBS and lysed in 200 μl 0.1 M NaOH and used for protein detection using 
Biorad protein assay. Manganese content was assessed in control and CORM-treated cells 
and in the corresponding nuclear fractions and the values normalised per amount of 
protein (180 ±16 mg per Petri-dish). 
Computational Details.  
Geometry optimizations, as well as frequency calculations for all molecules, were 
performed at the Density Functional level of theory with the Gaussian03 program 
package53 using the hybrid B3LYP functional54 in conjunction with the LanL2DZ basis 
set. 55-57 Pure basis functions (5d, 7f) were used in all calculations. Geometries were fully 
optimized without symmetry restrictions. The nature of the stationary points was checked 
by computing vibrational frequencies in order to verify true minima. The molecular 
structures of B12-MnCORM-1 and B12-MnCORM-1a were optimized by the two-layer 
ONIOM method58, 59 using the DFT method B3LYP/LanL2DZ for the high layer and the 




Cyanocobalamin (135 mg, 0.1 mmol) was dissolved in 10 ml of dry DMSO. A total of 
24.6 mg of carbonylditriazole (CDT) (0.15 mmol) was added. After stirring at RT 
overnight, 200 mg of tacd (where tacd = 1,4,8,11-tetraazacyclotetradecane, 1 mmol) were 
added. The mixture was stirred for 24h and then dried under vacuum. The resulting red 
-tacd (1).  
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powder was purified by preparative HPLC to yield 120mg (75.8%) of 1. Analytical data 
for 1: HPLC: retention time 7.9 min. ESI-MS analysis (positive mode) gave peaks at m/z 
= 1582.2 [M+] and 791.8 [M+H+]2+. 13C NMR, 100 MHz (D2O, δ ppm): 18.0; 18.2; 18.6; 
19.6; 21.9 (3C); 22.0; 22.2; 22.7; 28.0; 28.8 (1-2C); 30.8; 34.1; 34.2; 34.6; 35.0; 35.5; 
37.5; 37.7 ; 41.8; 45.6; 45.7; 45.9 (3C); 48.1(1-3C); 49.4(2C); 50.1; 50.9; 54.2; 56.6; 58.5; 
59.1; 62.0; 65.8; 71.4; 75.5; 75.8; 75.9; 77.7; 81.9; 87.9; 89.7; 97.8; 106.9; 110.3; 114.1; 
119.4; 132.8; 135.8; 137.9; 139.5; 144.6; 158.8  168.1; 168.8; 176.4; 177.5; 177.9; 178.5; 
178.0; 179.7; 180.0; 180.7; 181.0; 181.7; 182.8; I.r. (solid state, KBr, cm-1): νC≡N
Synthesis of B
 2134.   
12-[(tacd)MnI(CO)3](CF3CO2) (B12
A total of 115 mg of 1 (0.074 mmol) was dissolved in 4 ml of dry MeOH. To the solution 
89 mg of [Mn
-MnCORM-1).   
IBr(CO)5] (0.3 mmol, 4.5 eq) and 100 µl of triethylamine (TEA) were 
added. After 24h of stirring at RT, the solution was dried under vacuum. The resulting red 
powder was purified by preparative HPLC to yield 23mg (18.1%) of the desired product. 
Analytical data for B12-MnCORM-1: HPLC: retention time 21.9 min. ESI-MS analysis 
(positive mode) gave peaks at m/z = 1720.6 [M+] and 860.7 [M+H+]2+. 13C NMR, 100 
MHz (D2O, δ ppm): 18.0 (2C); 18.5; 19.3; 21.5 (3C); 21.9; 22.1 (2C); 28.5 (2C); 30.5; 
33.8; 34.2 (2C); 34.9 (2C); 37.5 (2C); 41.5; 45.3; 45.5 (3C); 48.0; 49.1 (4C); 50.1 (3C); 
50.8 (2C); 54.2; 56.0; 58.2; 58.8; 62.0; 63.0; 71.4; 75.5 (2C); 77.5; 84.6; 87.9; 89.5; 97.5; 
107.0, 110.3; 114.0; 119.1; 132.7; 135.8; 137.8; 139.5; 144.3; 168.5 (2C); 176.4; 177.7 
(2C); 178.6 (2C); 179.8, 180.0, 180.7 (2C); 181.0; 182.8; 195.1 (3C).  I.r. (solid state, 
KBr, cm-1): νC≡O  2026, 1922; νC≡N  2134. In this reaction a second minor product (B12-
MnCORM-1a, vide infra) was also identified and isolated. Yield 3.8mg (3 %). Analytical 
data for B12-MnCORM-1a: HPLC: retention time 23.9 min. ESI-MS analysis (positive 
mode) gave peaks at m/z = 1720.6 [M+] and 860.7 [M+H+]2+. I.r. (solid state, KBr, cm-1): 
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A total of 418 mg of Mn(CO)
]Br (2).   
5Br (1.5 mmol) were dissolved in 7 ml of dry DMF. To the 
solution 300 mg of tacd (1.5 mmol, 1 eq) were added. After 24h of stirring at RT, the 
resulting yellow solution was dried under vacuum. The residue was then purified by 
preparative HPLC to yield 293mg (57%) of 2. Analytical data for 2. Anal. Calc. for 
C13H24Br1N4O3Mn (419.2): C 37.25%, H 5.77%, N 13.37%. Found: C 37.58%, H 6.01%, 
N 13.45%.  HPLC: retention time 19.8 min. ESI-MS analysis (positive mode) gave a 
single peak at m/z = 339.2 [M+]. I.r. (solid state, KBr, cm-1): νC≡O
 
 2031, 1922. 
Fibroblast Cell Culture for FTIR Spectromicroscopy Measurements. 
NIH 3T3 Swiss Albino Mouse Fibroblast cells (ECACC Catalogue Number 85022108) 
were cultured directly on CaF2 windows (Crystran, Poole, UK) in Dulbecco’s Modified 
Eagle Medium (DMEM) containing 5 mM glucose and 10% fetal bovine serum (FBS). 
Cells were grown for 16 to 24 hours, until the desired degree of coverage was obtained 
(about 20% - 30%). The cell-coated window was transferred to a custom-built solution 
sample holder for FTIR microscopy, as previously described.38
 
 All cell culture materials 
were purchased from Invitrogen (Invitrogen, Life Technologies, Paisley, UK). 
Fibroblast Cell Treatment. 
Cell treatment with the CORM was performed under dim light. Additon of B12-
MnCORM-1 was performed by first removing bulk DMEM medium and covering the 
window with a DMEM solution of B12-MnCORM-1 of 0.1-1 mM. The sample holder was 
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then enclosed, kept at 37°C and used for FTIR spectromicroscopy measurements.  
 
FTIR Spectromicroscopy Measurements. 
FTIR Spectromicroscopy experiments were performed at beamline X01DC of the Swiss 
Light Source, comprising a Bruker Vertex 70v interferometer (Bruker Optics) and a 
Bruker Hyperion 3000 microscope. For these measurements, a KBr-supported Ge-
multilayer beamsplitter was used together with a liquid nitrogen-cooled MCT detector. 
The interferometer was scanned with an acquisition rate of 40 kHz to 4 cm-1 resolution. 
Measurements were performed in transmission. 250 scans were collected for each 
measurements, with a 60 s interval between measurements. Single channel spectra were 
obtained by performing a Fourier Transform of the interferogram after apodization with a 
Blackman-Harris 3-Term function, using a zero-filling factor of 2 and a Mertz phase 
correction.  
 
In a single cell photolysis experiment, an isolated cell was selected under the IR 
microscope using weak illumination. The confocal apertures where closed to limit the 
field probed by the IR light to a rectangle corresponding to the body of the cell. In the 
case of measurements on 3T3 fibroblasts, this selection excludes the filipodia. The cell 
was monitored for a few minutes by measuring sequential FTIR spectra in dim light. 
During this period, uptake of B12-MnCORM-1 was followed by observing the increase of 
absorption bands due to the CO ligands of B12-MnCORM-1 at 2027 cm-1 and 1931 cm-1
 
. 
After 60 min the cell was irradiated with the full spectrum from the 100W halogen lamp 
of the microscope illuminator and photolysis of the CORM was followed by the decrease 
of the same bands.  
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FTIR Mapping Measurements.  
The distribution of IR absorption bands was recorded by mapping the sample over a 
rectangular grid pattern.  For the higest resolution maps, confocal blades were set to a 
square aperture of 5x5 µm2 and point spacing was set at 2.5 µm. Using a 36x objective 
with 0.5 NA, these conditions give a theroetical spatial resolution close to the diffraction 
limit at the walength of absorption of CO ligands. For low resolution maps, confocal 
blades were set to an aperture of 10x10 µm2
 
 and point spacing was set at  5 or10 µm. 
Data Analysis. 
FTIR data analysis and assembly of IR maps was performed using the software package 
OPUS 6.5 (Bruker Optics). Spectral plots were constructed using Origin 8.0  (Originlab, 
Northampton, MA,USA). 
 
Fibroblast Cell Culture for Biological Tests. 
After 5-8 passages 3T3 cells were cultured in DMEM supplemented with 5 mM glucose and 
10% FBS plus penicillin-streptomycin at pH 7.4. About one million cells were plated per Petri 
dish of 4.5 cm2 area and kept proliferating to near confluence at 37 ºC in the presence of 95% 
air and 5% CO2 as described earlier.7
 
 Thereafter, the medium was exchanged in order to 
establish the following experimental conditions.  
Normoxic control cultures containing 5 mM glucose and 10% FBS were kept at pH 7.4 with 
phosphate buffered saline (PBS). Metabolically depleted cells were cultured in DMEM 
without glucose nor FBS in an incubator with a gas phase containing 0.2% O2, 5% CO2 and 
94.8% N2 (hypoxia) at 37 ºC and pH 7.4. Stock solution of B12-MnCORM-1 was taken up in 
PBS and added under dim light to give a final concentration of 30 µM to both normoxic and 
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metabolically depleted cultures as indicated in figure 6. Ten minutes after administration of 
B12
Responses of cells to metabolic depletion were followed from 2 till 48 hours as reflected in 
the proportion of live and dead cells attached to the bottom of the culture dishes. Cell cultures 
were stained for 10 min with a mixture of 10 µg/ml Hoechst-33342 and 10 µg/ml propidium 
iodide (PI) (Invitrogen, Molecular Probes). Hoechst-33342 (excitation and emission maxima 
360 and 450 nm, respectively) is membrane-permeable and stains the nuclei of all cells by 
binding to double-stranded nuclear DNA. Membrane-impermeable PI (excitation and 
emission maxima 555 and 620 nm, respectively) intercalates with DNA and RNA and is 
commonly used for identifying dead cells with ruptured plasma membrane. Fluorescent 
staining was recorded using the Axiovert 200-M fluorescent microscope and analyzed using 
MCID
-MnCORM-1 half of the cultures were exposed to light (xenon lamp at a distance of 10 
cm) for 15 min and the other half kept in darkness. The light-exposed cultures were 
subsequently kept under bench light during the whole experiment whereas those in the dark 
remained protected from light for the rest of the incubation time. 
TM image analysis software.7
In each culture dish cells were counted in 5 predetermined areas of 0.5 mm
 Staining with Alexa Fluor® 488 phalloidin (0.1 µM final 
concentration) was used to visualize the F-actin cytoskeleton. This double staining was 
performed after twice washing with PBS, fixation with 4% paraformaldehyde, and 
permeabilisation with 0.2% Triton X-100. 
2, totalling 2.5 
mm2
 
 per dish. After checking for normal distribution statistical analysis by one-way 
ANOVA was performed by non-paired Student's t-test using GraphPad Instat (GraphPad 
Inc. La Jolla, CA). Data are expressed as means (5 independent experiments each) ± SEM 
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